Would you like to relax knowing your immunological status? Get tested for Sars-Cov-2

For the time being, avoiding contagion is everyone's responsibility.

PCR

This is the reference technique for diagnosing the SARS-CoV-2 virus in the early stages of the disease since it is a very sensitive system, able to detect very low amounts of virus. However, it does not in itself differentiate the stage of the disease the patient may be in: onset, acute phase, or recovery phase. If a negative result is obtained from a patient with high suspicion of SARS-CoV-2 virus infection, it should be confirmed with a new test.

Sampling is performed via the nasopharyngeal route and thus is not necessary to attend on an empty stomach.


PCR saliva test

This test consists of the amplification of RNA of the SARS-CoV-2 coronavirus from a saliva sample. It is a highly sensitive test of choice for the diagnosis of active infection.

The great advantage of this test is the convenience of extraction, since it can be done at home and without the need for invasive extraction. The kit contains all the elements and instructions for the extraction and subsequent shipment to the laboratory.

Buy your Kit here.

Rapid Antigen Test

Detection of the virus from the beginning of contagion with high result reliability. The main advantage of this new test is the speed with which the result is obtained (15min), which allows greater agility in decision-making both individually and as a group.

Sampling is performed via the nasopharyngeal route and thus is not necessary to attend on an empty stomach.

Rapid Antigen Test with LumiraDx technology

The incorporation of Lumira Dx in the analysis of the sample allows a more accurate and earlier diagnosis, extending the window of detection days from 7 to 12, with greater sensitivity (99%).

The sampling is nasal which less invasive for the patient with respect to the nasopharyngeal route.

Elisa test

Detection of IgM and IgG type antibodies against COVID-2019 (SARS-CoV-2) using the reference test (ELISA / Chemiluminescence): Quantitative immunoassay and CE marked.

  • IgM-type antibodies are markers of recent infection and are detected in 90% of cases between days 4 to 7 of infection, continue to increase until day 14, and then begin to decrease.
  • IgG antibodies are detected somewhat later (on average day 8 post infection), and increase up to approximately 3 weeks. The sensitivity and specificity of the serological test we perform is close to 100%. It should be mentioned that the detection test for IgM and IgG antibodies against COVID-19 by immunoassay is NOT the rapid test for antibody detection.

Sampling is performed via conventional blood withdrawal and it is not necessary to attend on an empty stomach.

Rapid tests

These enable us to attain the patient's antibodies through them binding to the virus proteins deposited on a medium, producing visible colouration that is usually produced by colloidal gold. This range is therefore associated with the presence of specific antibodies and some tests (but not all) make it possible to distinguish whether they are IgM or IgG. They only detect the virus antibodies and not others associated with other infections or pathologies. The test takes about 15-20 minutes.

Sampling is performed via a drop of blood and it is not necessary to attend on an empty stomach.